Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia

Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia

Purpose: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we investigated the effects of preoperative 5ARI use in this setting. Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Jae Seung Chung, Won Ik Seo, Cheol Kyu Oh, Seong Cheol Kim, Myung Chan Park, Sang Hyun Park, Jihyeong Yu, Chan Ho Lee, Wansuk Kim, Tae Yong Park, Kweon Sik Min, Jae Il Chung
Format: Article
Language:English
Published: Korean Urological Association 2020-01-01
Series:Investigative and Clinical Urology
Subjects:
laser therapy
prostatic hyperplasia
thulium
5-alpha reductase inhibitors
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-67.pdf

Internet

https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-67.pdf

Similar Items